TRUDIE JOHNSON: Open Payments
NPI 1295999480 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 52 payments from 10 companies in 2025. Trend: 2023 $419 · 2024 $1,037 · 2025 $1,207
Food & beverage: $1,202Education: $5
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $259 |
| ABBVIE INC. | 8 | $234 |
| Neurocrine BioSciences, Inc. | 11 | $223 |
| Janssen Pharmaceuticals, Inc | 8 | $148 |
| Teva Pharmaceuticals USA, Inc. | 7 | $139 |
| Lundbeck LLC | 3 | $69 |
| Tris Pharma Inc | 3 | $69 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: FANAPT, VRAYLAR, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, REXULTI, Dyanavel XR, SPRAVATO.
Industry payments across WI — which companies pay providers there.
